You are here

Article info

Article menu
Clinical and epidemiological research
Extended report
Long-term safety of pegloticase in chronic gout refractory to conventional treatment

Authors

  1. Correspondence to Dr Michael A Becker, 237 East Delaware Pl, Chicago, IL 60611-1713, USA; mbecker{at}medicine.bsd.uchicago.edu
View Full Text

Citation

Becker MA, Baraf HSB, Yood RA, et al
Long-term safety of pegloticase in chronic gout refractory to conventional treatment
Annals of the Rheumatic Diseases 2013;72:1469-1474.

Publication history

  • Accepted August 9, 2012
  • First published November 10, 2012.
Online issue publication 
July 11, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/